Blood donor genotyping for prediction of blood group antigens: Results from 5 years' experience (2017–2022)
Vox Sanguinis · 2023-11 · 118 (11) · 980-987
DOI: 10.1111/vox.13524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 06.09.2023. Verfasst von Klaus Rieneck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Blood Group Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives For 5 years, routine genotyping has been performed for selected blood groups of blood donors in the Copenhagen Capital Region, Denmark. The result is summarized in the following. Materials and Methods Genotyping was carried out by an external service provider using the competitive allele specific PCR (KASP) technology. The genotypes were returned to the blood bank and translated into phenotypes by a proprietary IT application.
Results
In total, 65 alleles from 16 blood group systems (ABO, MNS, Rh, Lutheran, Kell, Duffy, Kidd, Diego, Yt, Dombrock, Colton, Landsteiner‐Wiener, Cromer, Knops, Vel, secretor status) and the HPA1, HPA5 and HPA15 antigens were interrogated. After translation, phenotypes were imported into the laboratory information management system of the blood bank. The results from 31,538 genotyped blood donors were used to calculate the allele frequencies for a Danish blood donor population. ABO genotyping was done for sample ID purposes. Determination of the 1061delC single nucleotide polymorphism (SNP) (NM_020469.2), most frequently characteristic of ABO*A2 , was validated against a series of 1287 samples with Dolichos biflorus lectin determination of the A1 phenotype.
Conclusion
We report allele frequencies and phenotype frequencies for 16 blood groups from a total of 31,538 genotyped blood donors. Blood products were supplied from a total of 64,312 active blood donors, and of these active blood donors 25,396 (39.5%) were genotyped. These donors represent a valuable resource for patient treatment. This genotyping has enabled the provision of rare genotyped donor blood for patients with alloantibodies and rare reagent cells for serology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Klaus Rieneck, Grethe Risum Krog
Zitieren
APA
Rieneck, K., Krog, G. R., Clausen, F. B., Egeberg Hother, C., & Dziegiel, M. H. (2023). Blood donor genotyping for prediction of blood group antigens: Results from 5 years' experience (2017–2022). Vox Sanguinis, 118(11), 980-987. https://doi.org/10.1111/vox.13524
Vancouver
Rieneck K, Krog GR, Clausen FB, Egeberg Hother C, Dziegiel MH. Blood donor genotyping for prediction of blood group antigens: Results from 5 years' experience (2017–2022). Vox Sanguinis. 2023;118(11):980-987. doi:10.1111/vox.13524
BibTeX
@article{Rieneck2023,
author = {Rieneck, Klaus and Krog, Grethe Risum and Clausen, Frederik Banch and Egeberg Hother, Christoffer and Dziegiel, Morten Hanefeld},
title = {Blood donor genotyping for prediction of blood group antigens: Results from 5 years' experience (2017–2022)},
journal = {Vox Sanguinis},
year = {2023},
volume = {118},
number = {11},
pages = {980--987},
doi = {10.1111/vox.13524}
}
EUVIMED